Achillion Pharmaceuticals, Inc

Achillion Pharmaceuticals, Inc (ACHN) related to its sale to Alexion Pharmaceuticals, Inc. Under terms of the Merger, Achillion shareholders will have the right to receive $6.30 in cash per each Achillion common stock owned.

To receive more information regarding the investigation of Achillion Pharmaceuticals, Inc please fill out the form below.